Moderna's stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
ModernaModerna(US:MRNA) MarketWatch·2026-03-04 06:30

交易概述 - 该交易将为Moderna的疫苗产品组合提供“确定性” [1]